In another study that determined outcomes of controlled ovarian hyper-stimulation in women with thyroid autoimmune disease, oocyte pickup and embryo transfer, the performance of recombinant-FSH was significantly poorer in patients with thyroid autoimmune disease(12). Here, BRD2 is linked to autoimmune thyroid disease.